Fig. 2From: Improved diagnostics targeting c-MET in non-small cell lung cancer: expression, amplification and activation? a Distribution of positive and negative MET expression of NSCLC samples. b Intersection of MET positive Formalin- and HOPE- fixed NSCLC samples. c Mean of MET intensities of Formalin- versus HOPE- fixed NSCLC samplesBack to article page